[An immunologic method of producing antigens for the treatment and prevention of leishmaniasis]
- PMID: 2493318
[An immunologic method of producing antigens for the treatment and prevention of leishmaniasis]
Abstract
Antigens isolated from lysates of L. infantum promastigotes by electroelution from polyacrylamide gels and by gel filtration, have already been proven to induce anti-Leishmania protective immunity in BALB/c mice when injected subcutaneously. At the present time, five preparations including either Leishmania antigens or anti-idiotypic reagents as vaccines can be considered as candidates for immunoprophylaxis in natural hosts of Leishmania parasites. We present a new method for producing Leishmania antigenic preparations which is of considerable interest, since it can be proposed for immunotherapy and prevention of other parasitic, bacterial, viral and perhaps, retroviral diseases.
Similar articles
-
[Efficacy of the vaccination of C57BL/6 mice against infection with different species of Leishmania].C R Acad Sci III. 1985;301(18):803-6. C R Acad Sci III. 1985. PMID: 3936605 French.
-
Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization.J Immunol. 1989 Jun 15;142(12):4441-9. J Immunol. 1989. PMID: 2786033
-
Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.J Immunol. 1987 Jul 1;139(1):221-7. J Immunol. 1987. PMID: 3495599
-
Leishmania transmission-blocking vaccines: a review.East Afr Med J. 1999 Feb;76(2):93-6. East Afr Med J. 1999. PMID: 10442130 Review.
-
T-cell responses and immunity to experimental infection with leishmania major.Annu Rev Immunol. 1989;7:561-78. doi: 10.1146/annurev.iy.07.040189.003021. Annu Rev Immunol. 1989. PMID: 2653376 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical